ClinicalTrials.Veeva

Menu
BRCR Global - San Juan, PR logo

BRCR Global - San Juan, PR

Research site

Site insights

Top conditions

Top treatments

Ferric Maltol
Brenipatide
Pertuzumab
LY3502970
Ritonavir
Ibuzatrelvir
Iron
Ferrous Sulfate
LY3537031
Itraconazole

Parent organization

This site is a part of BRCR Global

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Patricia Gonzalez

Verified by this site

Active trials

8 of 12 total trials

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced sol...

Enrolling
HER2-positive Advanced Solid Tumor
Drug: Itraconazole
Biological: DB-1303/BNT323
New

The main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participan...

Not yet enrolling
Pulmonary Disease, Chronic Obstructive
Drug: Placebo
Drug: Brenipatide

This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism a...

Enrolling
Hypothyroidism
Drug: Levothyroxine
Drug: Armour Thyroid

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germ...

Active, not recruiting
Pneumococcal Disease
Biological: 15-valent pneumococcal conjugate vaccine (PCV15)
Biological: PG4

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germ...

Enrolling
Pneumococcal Disease
Biological: PG4
Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)

This is a Phase 3, randomized, actively controlled, double-blinded, double-dummy, superiority study to evaluate the efficacy and safety of ibuzatrelv...

Enrolling
COVID-19 Infection
Drug: remdesivir
Drug: placebo for ibuzatrelvir

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1305/BNT325 in subjects with advanced sol...

Active, not recruiting
Advanced Solid Tumor
Drug: DB-1305/BNT325
Drug: BNT327

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germ...

Enrolling
Pneumococcal Disease
Biological: PG4
Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)

Trial sponsors

Pfizer logo
D
Lilly logo
AbbVie logo
H
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems